XP Chemistries AB (publ) (XPC.ST) Research
As a biotechnology company, XP Chemistries AB specializes in the development and production of forest-derived capsaicin and its related compounds. Its diverse offerings include ingredients for animal nutrition, components for cosmetic formulations, high-purity capsaicinoids, and active agents for self-defense products. Founded in 2018, the Swedish firm operates from its base in Sundsvall.
Market snapshot
- Symbol
- XPC.ST
- Price
- $0.17
- Day change
- +1.18%
- Market cap
- $34.0M
- P/E ratio
- -3.89x
- 52-week range
- 0.148-0.41
- Sector
- Basic Materials
- Industry
- Chemicals
Peer companies
Open XP Chemistries AB (publ) (XPC.ST) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.